German pharma firm Dermapharm buying Canopy’s cannabinoid subsidiary C3 (This story has been updated with comments and more details.) German pharmaceutical manufacturer Dermapharm Holding SE has struck a deal to buy C3 Cannabinoid Compound Co. GmbH from Canadian cannabis producer Canopy Growth. As part of the deal – expected to close in early 2022 – Dermapharm will […]
